Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Neoplasms of the CNS

Free Subscription 03.11.2025 1 AJNR Am J Neuroradiol 2 BMC Cancer 2 Childs Nerv Syst 1 Int J Radiat Oncol Biol Phys 18 J Neurooncol 3 J Neurosurg 7 Neuro Oncol 1 Neurol Res 2 Neuroradiology 1 Neurosurgery 1 Oncogene 5 PLoS One 2 Pol J Radiol 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. MARK IT, George J, Habibi P, Shinya Y, et al
   The Incidence of Calcified Pituitary Macroadenomas: Challenging the Craniopharyngioma Assumption.
   AJNR Am J Neuroradiol. 2025 Oct 24:ajnr.A9064. doi: 10.3174/ajnr.A9064.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ESTABILLO LL, Skaga E, Halldorsson S, Vik-Mo EO, et al
   Drug resistant glioblastoma stem cells exhibit enriched stemness signatures and share extracellular matrix overexpression.
   BMC Cancer. 2025;25:1655.
   PubMed         Abstract available
   
   
3. LU S, Xu L, Lan Y, Wang C, et al
   Study of plasma exosomal miRNAs as novel biomarkers for differentiating primary central nervous system lymphoma and glioblastoma.
   BMC Cancer. 2025;25:1657.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

4. OBENG-GYASI B, Line TA, Chinthala AS, Tailor J, et al
   Subtotal tumor resection as a predictor of post-resection hydrocephalus in pediatric patients with posterior fossa tumors.
   Childs Nerv Syst. 2025;41:332.
   PubMed         Abstract available
   
   
5. BASHIR F, Hussain N, Qureshi BM, Khandwala K, et al
   Clinical profile and outcomes of pediatric ependymoma: a 10-year retrospective analysis from a resource-limited setting.
   Childs Nerv Syst. 2025;41:330.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

6. LIN T, Ke S, Hu C, Assadi R, et al
   Low Dose Fractionated Radiation Therapy As a Chemo-Potentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase I/II Trial.
   Int J Radiat Oncol Biol Phys. 2025 Oct 23:S0360-3016(25)06396.
   PubMed         Abstract available
   
   

   
   J Neurooncol

7. HOOSEMANS LJN, Panayotopoulos LF, van Kuijk SMJ, Verduin M, et al
   Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
   J Neurooncol. 2025;176:42.
   PubMed         Abstract available
   
   
8. GHALIBAFIAN M, Mirzaei S, Sadeghi Y, Afsar N, et al
   Diffuse pontine glioma (DPG): shorter or longer treatment time?
   J Neurooncol. 2025;176:40.
   PubMed         Abstract available
   
   
9. TAS KT, Hoft FS, Agolli L, Mohamed TA, et al
   Long-term outcomes and toxicity of radiotherapy for WHO Grade II and III meningiomas: a retrospective analysis of 98 patients.
   J Neurooncol. 2025;176:41.
   PubMed         Abstract available
   
   
10. ZHANG XF, Liang YZ, Wu HY, Chen JL, et al
    Navigating heterogeneity in resected brain metastases: molecular stratification and multimodal therapeutic strategies.
    J Neurooncol. 2025;176:43.
    PubMed        
    
    
11. TOPKAN E, Ozturk D
    Letter to the editor: a comparison of outcomes after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases: an international multi-center study.
    J Neurooncol. 2025;176:48.
    PubMed        
    
    
12. MYNENI S, Bhandarkar S, Akbari H, Mayne R, et al
    The Craniopharyngioma Quality of Life (C-QOL) Index: a preliminary disease-specific, patient-centered tool for assessing patient reported outcomes in adult craniopharyngioma patients.
    J Neurooncol. 2025;176:45.
    PubMed         Abstract available
    
    
13. LI L, Shao MY, Zou SC, Xiao ZF, et al
    Retraction Note: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
    J Neurooncol. 2025;176:44.
    PubMed        
    
    
14. JI P, Li C, Wang Y, Guo S, et al
    Clinical and survival differences between thalamic glioblastoma and thalamic diffuse midline glioma, H3 K27-altered.
    J Neurooncol. 2025;176:46.
    PubMed         Abstract available
    
    
15. SUN Y, Hamo M, Atchley T, Markert JM, et al
    Survival outcomes associated with antidepressant use in glioblastoma: a cohort study.
    J Neurooncol. 2025;176:47.
    PubMed         Abstract available
    
    
16. BUCCILLI B, Yoon J, Hussein A, Faraji A, et al
    Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study.
    J Neurooncol. 2025;176:50.
    PubMed         Abstract available
    
    
17. DEL BALDO G, Di Ruscio V, Cacchione A, Lo Sasso A, et al
    Clinical, toxicity and long-term neurocognitive outcomes of first-line intensive chemotherapy in infant medulloblastoma: a single-center cohort study following AIEOP recommendations.
    J Neurooncol. 2025;176:54.
    PubMed         Abstract available
    
    
18. PEETERS S, Kim WJ, Armellini A, Haist B, et al
    The activity of cold atmospheric plasma against high-grade glioma: a review.
    J Neurooncol. 2025;176:52.
    PubMed         Abstract available
    
    
19. CHEN ZHOU ZH, Hilario A, Salvador Alvarez E, Cardenas Del Carre A, et al
    Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery.
    J Neurooncol. 2025;176:53.
    PubMed         Abstract available
    
    
20. GECICI NN, Stepniak A, Habib A, Ghoche MT, et al
    Predictors and clinical implications of surgical site infections following glioma resection: a matched case-control study.
    J Neurooncol. 2025;176:55.
    PubMed         Abstract available
    
    
21. GULSUNA B, Stevens B, Gulsuyu B, Wood E, et al
    Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review.
    J Neurooncol. 2025;176:58.
    PubMed         Abstract available
    
    
22. CARMICHAEL A, Arshad U, Heinemann DM, Reddy SC, et al
    Radiologic characterization and clinical management of multinodular and vacuolating neuronal tumor (MVNT): a retrospective institutional cohort study.
    J Neurooncol. 2025;176:57.
    PubMed         Abstract available
    
    
23. BERTHOLD C, Boudreault A, Simonyan D, Fournier-Loiselle J, et al
    Hormonal factors predisposing to the development of meningiomas in men: a case-control study.
    J Neurooncol. 2025;176:61.
    PubMed        
    
    
24. ZHONG W, Li Z, Lv S, Chen G, et al
    Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma.
    J Neurooncol. 2025;176:59.
    PubMed         Abstract available
    
    

    
    J Neurosurg

25. ALEXIOU GA, Markopoulos G, Voulgaris S, Vartholomatos G, et al
    Letter to the Editor. Intraoperative flow cytometry for brain tumor margin evaluation.
    J Neurosurg. 2025 Oct 24:1-2. doi: 10.3171/2025.7.JNS251423.
    PubMed        
    
    
26. CORVINO S
    Letter to the Editor. Spheno-orbital meningioma: less is more.
    J Neurosurg. 2025 Oct 31:1-2. doi: 10.3171/2025.7.JNS251329.
    PubMed        
    
    
27. COULDWELL WT, Nassiri F, Rawanduzy C, Cole K, et al
    Resectability of spheno-orbital meningiomas: surgical outcome in 93 cases and a proposed clinically relevant anatomical classification.
    J Neurosurg. 2025 Oct 31:1-10. doi: 10.3171/2025.7.JNS242730.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

28. PINZI V, Kotecha R, Sahgal A, Gorgulho A, et al
    International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines for Radiosurgery in Recurrent High-Grade Glioma.
    Neuro Oncol. 2025 Oct 27:noaf247. doi: 10.1093.
    PubMed         Abstract available
    
    
29. HONG B, Su D, Cui X, Zhao J, et al
    PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization.
    Neuro Oncol. 2025 Oct 27:noaf253. doi: 10.1093.
    PubMed         Abstract available
    
    
30. ZHANG B, Zhang J, Li Z, Sheng H, et al
    Interrogation of the cellular hierarchies reveals neoplastic evolution and therapeutic vulnerability in craniopharyngioma.
    Neuro Oncol. 2025 Oct 24:noaf249. doi: 10.1093.
    PubMed         Abstract available
    
    
31. SMITH AKS, Dhanda SK, Billups CA, Sioson E, et al
    An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival.
    Neuro Oncol. 2025 Oct 24:noaf250. doi: 10.1093.
    PubMed         Abstract available
    
    
32. ARORA S, Nuechterlein N, Jensen M, Glatzer G, et al
    Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biology.
    Neuro Oncol. 2025 Oct 24:noaf251. doi: 10.1093.
    PubMed         Abstract available
    
    
33. TESKE N, Dono A, Young JS, Juenger ST, et al
    Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect group.
    Neuro Oncol. 2025 Oct 25:noaf239. doi: 10.1093.
    PubMed         Abstract available
    
    
34. SAVANI MR, El Shami M, Miki K, Gattie LC, et al
    Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment.
    Neuro Oncol. 2025 Oct 25:noaf248. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Res

35. SELVA BIRUNDA S, Kaliappan M, Ramana R
    An explainable modified convolutional mixer neural network-based deep learning framework for accurate brain tumor detection and classification.
    Neurol Res. 2025 Oct 31:1-16. doi: 10.1080/01616412.2025.2574357.
    PubMed         Abstract available
    
    

    
    Neuroradiology

36. VANDENDRIESSCHE C, Bouzerar R, Zemani A, Broutin C, et al
    Evaluation of an abbreviated MRI protocol in the screening for brain metastases in the initial staging of lung cancer.
    Neuroradiology. 2025 Oct 25. doi: 10.1007/s00234-025-03817.
    PubMed         Abstract available
    
    
37. HE J, Cheng Y, Pan Y, Zeng Q, et al
    Comparison of multiple tractography pipelines for corticospinal tract reconstruction applied to brain tumor patients.
    Neuroradiology. 2025 Oct 29. doi: 10.1007/s00234-025-03793.
    PubMed         Abstract available
    
    

    
    Neurosurgery

38. MENG Y, Tsang DS, Bernstein K, Santhumayor B, et al
    Hypofractionation of Gamma Knife Radiosurgery for Intracranial Meningiomas: A Retrospective Multicenter Study and Systematic Review of Literature.
    Neurosurgery. 2025 Oct 27. doi: 10.1227/neu.0000000000003809.
    PubMed         Abstract available
    
    

    
    Oncogene

39. ZUO M, Zhang S, Chen S, He Y, et al
    Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling.
    Oncogene. 2025 Oct 24. doi: 10.1038/s41388-025-03601.
    PubMed         Abstract available
    
    

    
    PLoS One

40. WU Y, Ren Y, Li S, Zeng M, et al
    Association between intraoperative hypotension during brain tumor resection and postoperative delirium: A secondary analysis of a randomized controlled trial.
    PLoS One. 2025;20:e0334094.
    PubMed         Abstract available
    
    
41. YUAN W, Kang H
    Enhanced local feature extraction of lite network with scale-invariant CNN for precise segmentation of small brain tumors in MRI.
    PLoS One. 2025;20:e0334447.
    PubMed         Abstract available
    
    
42. SHERWOOD M, Nicholas B, Bailey A, Mitsugi TG, et al
    Identification of natural Zika virus peptides presented on the surface of paediatric brain tumour cells by HLA class I.
    PLoS One. 2025;20:e0335726.
    PubMed         Abstract available
    
    
43. MALLOUH M, De la Cruz-Ku G, Luque-Benavides R, Valcarcel B, et al
    Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohort.
    PLoS One. 2025;20:e0333611.
    PubMed         Abstract available
    
    
44. ALHASSAN AM, Altmami NI
    IV3TM: Inception V3 enabled bidirectional long short-term memory network for brain tumor classification.
    PLoS One. 2025;20:e0335397.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

45. KUZAN BN, Ilgin C, Gecmen GG, Isik N, et al
    Can radiomics in brain magnetic resonance imaging predict the mutational status of primary lung cancer based on brain metastasis?
    Pol J Radiol. 2025;90:e475-e483.
    PubMed         Abstract available
    
    
46. VIJAN A, Nair SM, Sahu A, Chopade P, et al
    High-grade gliomas associated with neurofibromatosis type 1: analysis of imaging features and literature review.
    Pol J Radiol. 2025;90:e458-e464.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

47. MELSSEN M, Dimberg A
    Keeping Wnt in check for efficient checkpoint blockade in glioblastoma.
    Proc Natl Acad Sci U S A. 2025;122:e2523639122.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.